id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1980-N-0038-0651,FDA,FDA-1980-N-0038,Final Decision from FDA OC to Buchanan Ingersoll & Rooney PC,Other,Decision,2020-09-30T04:00:00Z,2020,9,2020-10-16T04:00:00Z,,2020-10-16T17:10:58Z,,0,0,090000648491383f
FDA-1980-N-0038-0650,FDA,FDA-1980-N-0038,Petition for Stay of Action for Hyrex from Buchanan Ingersoll & Rooney PC,Other,Petition(s),2020-09-22T04:00:00Z,2020,9,2020-09-22T04:00:00Z,,2020-09-22T16:29:21Z,,0,0,090000648486f056
FDA-1980-N-0038-0648,FDA,FDA-1980-N-0038,Request for Appeal from Buchanan Ingersoll & Rooney PC,Other,Appeal,2020-08-14T04:00:00Z,2020,8,2020-08-14T04:00:00Z,,2020-08-14T20:59:44Z,,0,0,09000064847fe61c
FDA-1980-N-0038-0646,FDA,FDA-1980-N-0038,"Vioform-Hydrocortisone Cream, Ointment, and Lotion Containing
Iodochlorhydroxyquin and Hydrocortisone; Final Decision on
Proposal To Withdraw Approval of New Drug Applications; Opportunity
To Affirm Outstanding Appeal",Notice,Withdrawal,2020-07-15T04:00:00Z,2020,7,2020-07-15T04:00:00Z,2020-08-15T03:59:59Z,2020-08-14T01:01:09Z,2020-15298,0,0,09000064847633da